Dr. Bill Morice reveals how data is reshaping clinical diagnostics
Data has always been central to patient care and medical research, but today it is driving healthcare transformation at an unprecedented pace. In an article for “Becker’s Hospital Review,” William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, shares insights on how this data revolution is shaping clinical diagnostics.
One major outcome of the convergence of data and advanced capabilities is the acceleration of innovation and medical research.
Massive datasets can now be analyzed rapidly and deeply, uncovering patterns that were previously undetectable. This fuels breakthroughs in disease diagnosis, treatment, and prevention, while AI’s continuous learning creates a feedback loop that enhances precision and sparks new clinical discoveries.
The changing data landscape also highlights the role of laboratories in developing and using technologies to support more personalized care.
One of the most significant outcomes is the rise of personalized medicine. Clinicians increasingly have access to data-driven tools to predict disease progression and tailor interventions earlier and more accurately. Laboratories play a critical role in this shift, as diagnostic data powers these tools, making lab professionals essential partners in advancing individualized care.
To realize this potential, laboratorians must evolve from result generators to data stewards, interpreters, and innovators to ensure accurate interpretation, ethical AI use, and robust data models. This calls for rethinking medical education and professional development. Realizing the full potential that this growing data resource creates requires equipping laboratory professionals and clinicians with the skills to use and govern data responsibly.
